Publications
SELECTED PUBLICATIONS
Short-term Topiramate treatment prevents radiation-induced cytotoxic edema in preclinical models of breast-cancer brain metastasis.
Maria J. Contreras-Zárate, Karen LF. Alvarez-Eraso, Jenny A. Jaramillo-Gómez, Zachary Littrell, Niki Tsuji, David R. Ormond, Sana D Karam, Peter Kabos, Diana M. Cittelly
doi: https://doi.org/10.1101/2023.02.14.528559
IL13Rα2 promotes proliferation and outgrowth of breast cancer brain metastases.
Marquez-Ortiz RA, Contreras-Zárate MJ, Tesic V, Alvarez-Eraso KL, Kwak G, Littrell Z, Costello JC, Sreekanth V, Ormond DR, Karam SD, Kabos P, Cittelly DM*.
Clin Cancer Res. 2021 Sep 20:clincanres.0361.2021.
Combination of trastuzumab emtansine and stereotactic radiosurgery results in high rates of clinically significant radionecrosis and dysregulation of Aquaporin-4.
Stumpf PK*, Cittelly DM*, Robin TP, Carlson JA, Sthr KA, Contreras-Zárate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovithc R, Kavanagh B, Liu A, Diamond JR, Kabos PK, Fisher CM. *Co-first authors.
Clin Cancer Res. 2019 Apr 2. pii: clincanres.2851.2018.
Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
Contreras-Zárate MJ, Day NL, Ormond DR, Borges VF, Tobet S, Gril B, Steeg P, Cittelly DM.
Oncogene. 2019.
Readers’ Choice: The best of Oncogene 2019
Development of Novel Patient-Derived Xenografts from breast cancer Brain metastases.
Contreras-Zárate MJ, Ormond DR, Gillen AE, Hanna C, Day NL, Serkova NJ, Jacobsen BM, Edgerton SM, Thor AD, Borges VF, Lillehei KO, Graner MW, Kabos P, Cittelly DM.
Front Oncol. 2017 Nov 2; 7:252. doi: 10.3389 /fonc.2017.00252. eCollection 2017.
Labeling of breast cancer patient-derived xenografts with traceable reporters for tumor growth and metastasis studies.
Hanna CT, Kwok L, Finlay-Schultz J, Sartorius CA, Cittelly DM.
Jove. 2016; (117).
Estrogen promotes the brain metastatic colonization of triple negative breast cancer via an astrocyte-mediated paracrine mechanism.
Sartorius CA, Hanna CP, Gril B, Cruz H, Kabos P, Serkova NJ, Huber KM, Schedin TB, Borges VF, Steeg PS, Cittelly DM.
Oncogene. 2016; 35(22):2881-92.